Genmab A/S (GNMSF) Inventory (2023 - 2026)
Genmab A's (GNMSF) quarterly Inventory came in at $21.0 million in Q1 2026, up 75.0% YoY from $12.0 million in Q1 2025, and up 16.67% on a QoQ basis from $18.0 million in Q4 2025.
Genmab A/S (GNMSF) Inventory (2023 - 2026) Analysis & Trends
Genmab A (GNMSF) has 4 years of Inventory data on file, last reported at $21.0 million in Q1 2026.
- Quarterly Inventory rose 75.0% year-over-year to $21.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.0 million (up 75.0% YoY) and the FY2025 annual result came in at $18.0 million, up 100.0% from the prior year.
- Inventory improved to $21.0 million in Q1 2026, from $18.0 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $21.0 million in Q1 2026 to a low of $8.0 million in Q4 2023.
- A 4-year average of $13.6 million and a median of $13.0 million in 2025 frame the typical range for Inventory.
- Annual changes were most pronounced in 2024 — Inventory advanced 12.5% — and 2025, when it surged 100.0%.
- Tracing GNMSF's Inventory over 4 years: stood at $8.0 million in 2023, then increased by 12.5% to $9.0 million in 2024, then surged by 100.0% to $18.0 million in 2025, then rose by 16.67% to $21.0 million in 2026.
- The last three Inventory figures came in at $21.0 million (Q1 2026), $18.0 million (Q4 2025), and $14.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.00 Mn |
| Mar 31, 2026 | 21.00 Mn |
| Dec 31, 2025 | 18.00 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Jun 30, 2025 | 13.00 Mn |
| Mar 31, 2025 | 12.00 Mn |
| Dec 31, 2024 | 9.00 Mn |
| Dec 31, 2023 | 8.00 Mn |